Experts have hailed the drug, called Arimidex, as the biggest step forward in 20 years. Women diagnosed with early tumours could be taking it as a daily pill by the end of the year. Research ...

The UK pharma has already sold rights to both Arimidex and Casodex in the US in 2017. There were no closing conditions to the divestment and the agreement became effective on signing.